vs

Side-by-side financial comparison of MDU RESOURCES GROUP INC (MDU) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $522.6M, roughly 1.2× MDU RESOURCES GROUP INC). Royalty Pharma plc runs the higher net margin — 34.4% vs 14.6%, a 19.8% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -1.6%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -5.7%).

MDU Resources Group, Inc. is a U.S.-based corporation supplying products and services to regulated energy delivery and utilities related construction materials and services businesses. It is headquartered in Bismarck, North Dakota, and operates in 48 states.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

MDU vs RPRX — Head-to-Head

Bigger by revenue
RPRX
RPRX
1.2× larger
RPRX
$622.0M
$522.6M
MDU
Growing faster (revenue YoY)
RPRX
RPRX
+6.4% gap
RPRX
4.8%
-1.6%
MDU
Higher net margin
RPRX
RPRX
19.8% more per $
RPRX
34.4%
14.6%
MDU
Faster 2-yr revenue CAGR
RPRX
RPRX
Annualised
RPRX
4.6%
-5.7%
MDU

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDU
MDU
RPRX
RPRX
Revenue
$522.6M
$622.0M
Net Profit
$76.3M
$214.2M
Gross Margin
Operating Margin
20.5%
62.4%
Net Margin
14.6%
34.4%
Revenue YoY
-1.6%
4.8%
Net Profit YoY
38.4%
2.9%
EPS (diluted)
$0.37
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDU
MDU
RPRX
RPRX
Q4 25
$522.6M
$622.0M
Q3 25
$313.6M
$609.3M
Q2 25
$348.7M
$578.7M
Q1 25
$678.0M
$568.2M
Q4 24
$531.0M
$593.6M
Q3 24
$290.7M
$564.7M
Q2 24
$343.1M
$537.3M
Q1 24
$588.2M
$568.0M
Net Profit
MDU
MDU
RPRX
RPRX
Q4 25
$76.3M
$214.2M
Q3 25
$18.3M
$288.2M
Q2 25
$13.8M
$30.2M
Q1 25
$82.0M
$238.3M
Q4 24
$55.2M
$208.2M
Q3 24
$64.6M
$544.0M
Q2 24
$60.4M
$102.0M
Q1 24
$100.9M
$4.8M
Operating Margin
MDU
MDU
RPRX
RPRX
Q4 25
20.5%
62.4%
Q3 25
12.7%
70.1%
Q2 25
8.7%
36.3%
Q1 25
16.6%
94.0%
Q4 24
17.8%
60.9%
Q3 24
12.0%
Q2 24
11.5%
50.2%
Q1 24
16.4%
-13.0%
Net Margin
MDU
MDU
RPRX
RPRX
Q4 25
14.6%
34.4%
Q3 25
5.8%
47.3%
Q2 25
4.0%
5.2%
Q1 25
12.1%
41.9%
Q4 24
10.4%
35.1%
Q3 24
22.2%
96.3%
Q2 24
17.6%
19.0%
Q1 24
17.2%
0.8%
EPS (diluted)
MDU
MDU
RPRX
RPRX
Q4 25
$0.37
$0.49
Q3 25
$0.09
$0.67
Q2 25
$0.07
$0.07
Q1 25
$0.40
$0.55
Q4 24
$0.26
$0.46
Q3 24
$0.32
$1.21
Q2 24
$0.30
$0.23
Q1 24
$0.49
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDU
MDU
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$28.2M
$618.7M
Total DebtLower is stronger
$2.7B
$9.0B
Stockholders' EquityBook value
$2.8B
$9.7B
Total Assets
$7.6B
$19.6B
Debt / EquityLower = less leverage
0.97×
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDU
MDU
RPRX
RPRX
Q4 25
$28.2M
$618.7M
Q3 25
$75.9M
$938.9M
Q2 25
$58.8M
$631.9M
Q1 25
$59.5M
$1.1B
Q4 24
$66.9M
$929.0M
Q3 24
$88.3M
$950.1M
Q2 24
$78.8M
$1.8B
Q1 24
$72.7M
$843.0M
Total Debt
MDU
MDU
RPRX
RPRX
Q4 25
$2.7B
$9.0B
Q3 25
$2.4B
$8.9B
Q2 25
$2.2B
$8.0B
Q1 25
$2.2B
$7.6B
Q4 24
$2.3B
$7.6B
Q3 24
$2.3B
$7.6B
Q2 24
$2.3B
$7.6B
Q1 24
$2.3B
$6.1B
Stockholders' Equity
MDU
MDU
RPRX
RPRX
Q4 25
$2.8B
$9.7B
Q3 25
$2.7B
$9.6B
Q2 25
$2.7B
$9.5B
Q1 25
$2.7B
$9.8B
Q4 24
$2.7B
$10.3B
Q3 24
$3.1B
$10.3B
Q2 24
$3.0B
$9.8B
Q1 24
$3.0B
$9.9B
Total Assets
MDU
MDU
RPRX
RPRX
Q4 25
$7.6B
$19.6B
Q3 25
$7.2B
$19.3B
Q2 25
$6.9B
$18.3B
Q1 25
$7.0B
$17.6B
Q4 24
$7.0B
$18.2B
Q3 24
$8.2B
$18.0B
Q2 24
$8.0B
$17.7B
Q1 24
$7.8B
$16.1B
Debt / Equity
MDU
MDU
RPRX
RPRX
Q4 25
0.97×
0.92×
Q3 25
0.86×
0.93×
Q2 25
0.80×
0.84×
Q1 25
0.80×
0.78×
Q4 24
0.85×
0.74×
Q3 24
0.76×
0.74×
Q2 24
0.75×
0.78×
Q1 24
0.76×
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDU
MDU
RPRX
RPRX
Operating Cash FlowLast quarter
$80.6M
$827.1M
Free Cash FlowOCF − Capex
$-336.0M
FCF MarginFCF / Revenue
-64.3%
Capex IntensityCapex / Revenue
79.7%
Cash ConversionOCF / Net Profit
1.06×
3.86×
TTM Free Cash FlowTrailing 4 quarters
$-297.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDU
MDU
RPRX
RPRX
Q4 25
$80.6M
$827.1M
Q3 25
$57.9M
$702.6M
Q2 25
$117.4M
$364.0M
Q1 25
$217.5M
$596.1M
Q4 24
$60.5M
$742.5M
Q3 24
$140.2M
$703.6M
Q2 24
$136.5M
$658.2M
Q1 24
$165.1M
$664.6M
Free Cash Flow
MDU
MDU
RPRX
RPRX
Q4 25
$-336.0M
Q3 25
$-121.9M
Q2 25
$36.5M
Q1 25
$124.4M
Q4 24
$-95.8M
Q3 24
$673.0K
Q2 24
$26.5M
Q1 24
$48.1M
FCF Margin
MDU
MDU
RPRX
RPRX
Q4 25
-64.3%
Q3 25
-38.9%
Q2 25
10.5%
Q1 25
18.4%
Q4 24
-18.0%
Q3 24
0.2%
Q2 24
7.7%
Q1 24
8.2%
Capex Intensity
MDU
MDU
RPRX
RPRX
Q4 25
79.7%
Q3 25
57.3%
Q2 25
23.2%
Q1 25
13.7%
Q4 24
29.4%
Q3 24
48.0%
Q2 24
32.0%
Q1 24
19.9%
Cash Conversion
MDU
MDU
RPRX
RPRX
Q4 25
1.06×
3.86×
Q3 25
3.16×
2.44×
Q2 25
8.52×
12.06×
Q1 25
2.65×
2.50×
Q4 24
1.10×
3.57×
Q3 24
2.17×
1.29×
Q2 24
2.26×
6.45×
Q1 24
1.64×
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDU
MDU

Natural Gas Distribution$382.8M73%
Commercial Utility Sales$42.7M8%
Residential Utility Sales$33.7M6%
Pipelineand Midstream$31.1M6%
Natural Gas Transportation$17.2M3%
Industrial Utility Sales$10.1M2%
Natural Gas Storage$6.4M1%
Other Utility Sales$1.9M0%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons